B2V347 AF NFT

D-aminoacyl-tRNA deacylase

MOLNFT AF v1 smart contract in GenesisL1 blockchain: 
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
IPFS of NFT metadata: 
bafybeiezkiqvqe46eectbx75fmdvkjgijtno4vjykddud6ifn64nex7d6u/metadata.json
IPFS of structure file: 
bafybeigmnegg2xodfbtqxguaqtvz4yfbxi6db6kfcmrb3zig7rceys4ueu/AF-B2V347-F1-model_v2.pdb
First NFT owner address (eip-55): 
0xa73BAb1DabE4333A884D03393eAa10c3B4215494
First NFT owner address (bech32): 
genesis15ua6k8dtusen4zzdqvuna2sscw6zz4y5hahjw0
Current NFT ID #106162 owner (web3):

First owner GALLERY | EVM EXPLORER | COSMOS EXPLORER

MOLNFT AF v1

NFT id:
106162
Accession (UniProt):
B2V347
Name::
D-aminoacyl-tRNA deacylase
Experimental Method:
Predicted structure
Sequence source:
CLOSTRIDIUM BOTULINUM (STRAIN ALASKA E43 / TYPE E3)

NFT data

MolNFT AF v1 is an AlphaFold database of AI predicted Swiss-Prot protein sequences preserved as regular ERC-721 NFT tokens on GenesisL1 blockchain for public free use, research and entertainment:

https://alphafold.ebi.ac.uk/
Jumper, J., Evans, R., Pritzel, A. et al. Highly accurate protein structure prediction with AlphaFold. 
Nature 596, 583–589 (2021). https://doi.org/10.1038/s41586-021-03819-2

MOLNFT B2V347 research and analysis (ICN3D with VR)

FASTA sequences

>sp|B2V347|DTD_CLOBA D-aminoacyl-tRNA deacylase OS=Clostridium botulinum (strain Alaska E43 / Type E3) OX=508767 GN=dtd PE=3 SV=1 MRAVVQRVTSSSVKVEDNIVGSIGKGLNVLIGISKSDTLEDLKYIRDKVINLRIFQDEKEKMNLSLLDIKGELLVISQFTLYGDCRKGRRPNFMDAKGGEEAKELYEEFLSLLKESNLKVETGEFGADMKVEINNDGPVTIILDSSKNF